Literature DB >> 5522871

[Effect of the combined treatment of Parkinson patients with L-Dopa and a decarboxylase inhibitor (Ro4-4602). Quantitative analysis of bradykinesia by means of reaction time measurements].

W Kaufmann, P Butz, M Wiesendanger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5522871

Source DB:  PubMed          Journal:  Dtsch Z Nervenheilkd        ISSN： 0367-004X


× No keyword cloud information.
  6 in total

1.  Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.

Authors:  U K Rinne; V Sonninen; T Sirtola
Journal:  Z Neurol       Date:  1972

2.  [Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].

Authors:  W Gehlen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974-04-09

3.  [Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].

Authors:  E Schneider; P A Fischer; P Jacobi; H Maxion
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1973-03-19

4.  [The therapeutic effect of L-dopa].

Authors:  P Groneberg; A Struppler
Journal:  Naturwissenschaften       Date:  1972-11

5.  [Analysis of a rapid voluntary movement in Parkinsonian patients before and after stereotaxic thalamic lesions].

Authors:  P Butz; W Kafmann; M Wiesendanger
Journal:  Z Neurol       Date:  1970

6.  [Delayed initiation of voluntary movements after pyramidal lesions in man (author's transl)].

Authors:  R Jung; V Dietz
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1975-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.